Satya Yendluri

Intravenous administration of an AAV-2 vector for the expression of factor IX in mice and a dog model of hemophilia B

TC Harding, K Koprivnikar, GH Tu et al. · Gene Therapy · 2004 · 51 citations

Inflammation, Factor Ix, Autoimmune Disease +10

Enhanced Gene Transfer Efficiency in the Murine Striatum and an Orthotopic Glioblastoma Tumor Model, Using AAV-7- and AAV-8-Pseudotyped Vectors

Thomas C. Harding, Peter J. Dickinson, Byron N. Roberts et al. · Human Gene Therapy · 2006 · 46 citations

Immunology, Aav-8-pseudotyped Vectors, Gene Delivery +16

AAV Serotype 8-Mediated Gene Delivery of a Soluble VEGF Receptor to the CNS for the Treatment of Glioblastoma

Thomas C. Harding, Alshad S. Lalani, Byron N. Roberts et al. · Molecular Therapy · 2006 · 42 citations · Full text

The N-terminus of the <i>Begomovirus</i> Nuclear Shuttle Protein (BV1) Determines Virulence or Avirulence in <i>Phaseolus vulgaris</i>

Y.-C. Zhou, Eduardo Raymundo Garrido-Ramírez, Mysore R. Sudarshana et al. · Molecular Plant-Microbe Interactions · 2007 · 39 citations · Full text

Viral Replication, Amino Acids, Viral Polymerase Mechanism +22

Novel Immunocompetent Murine Tumor Model for Evaluation of Conditionally Replication-Competent (Oncolytic) Murine Adenoviral Vectors

Michael J. Robinson, Betty Li, Ying Ge et al. · Journal of Virology · 2009 · 39 citations · Full text